Business Description
ReproCELL Incorp
ISIN : JP3974770004
Total Employee Number:
110Description
ReproCELL Incorp is one of the stem cell research company in Japan. The company enables cell therapy developers with integrated, regulatory-aligned solutions from donor sourcing and cell derivation to gene editing and GMP manufacturing. The products of the company include Gen reprogramming kit, Hypoimmune cell lines, iPSC derived exosomes, tissue bioengineering, bioreactor systems, and others.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.93 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 11.88 | |||||
Beneish M-Score | -3.01 | |||||
WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -12.4 | |||||
3-Year EBITDA Growth Rate | -40 | |||||
3-Year EPS without NRI Growth Rate | -38.1 | |||||
3-Year FCF Growth Rate | -12.4 | |||||
3-Year Book Growth Rate | 1.5 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 62.99 | |||||
9-Day RSI | 62.77 | |||||
14-Day RSI | 62.17 | |||||
3-1 Month Momentum % | -32.77 | |||||
6-1 Month Momentum % | -30.8 | |||||
12-1 Month Momentum % | -45.83 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 11.86 | |||||
Quick Ratio | 11.27 | |||||
Cash Ratio | 10.21 | |||||
Days Inventory | 85.91 | |||||
Days Sales Outstanding | 49.63 | |||||
Days Payable | 39.67 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 46.26 | |||||
Operating Margin % | -38.19 | |||||
Net Margin % | -18.96 | |||||
EBITDA Margin % | -34.93 | |||||
FCF Margin % | -20.67 | |||||
OCF Margin % | -16.46 | |||||
ROE % | -4.96 | |||||
ROA % | -4.51 | |||||
ROIC % | -25.07 | |||||
3-Year ROIIC % | -40.33 | |||||
ROC (Joel Greenblatt) % | -194.95 | |||||
ROCE % | -9.85 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Forward PE Ratio | 52.22 | |||||
PS Ratio | 6.26 | |||||
PB Ratio | 1.64 | |||||
Price-to-Tangible-Book | 1.66 | |||||
EV-to-EBIT | -10.54 | |||||
EV-to-EBITDA | -11.52 | |||||
EV-to-Revenue | 4.03 | |||||
EV-to-FCF | -19.25 | |||||
Price-to-GF-Value | 0.94 | |||||
Price-to-Projected-FCF | 14.6 | |||||
Price-to-Median-PS-Value | 0.46 | |||||
| Price-to-Net-Current-Asset-Value | 2.61 | |||||
| Price-to-Net-Cash | 3.04 | |||||
Earnings Yield (Greenblatt) % | -9.49 | |||||
FCF Yield % | -3.24 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
ReproCELL Incorp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 12.705 | ||
| EPS (TTM) (€) | -0.025 | ||
| Beta | 0.433 | ||
| 3-Year Sharpe Ratio | -0.32 | ||
| 3-Year Sortino Ratio | -0.56 | ||
| Volatility % | 52.78 | ||
| 14-Day RSI | 62.17 | ||
| 14-Day ATR (€) | 0.049178 | ||
| 20-Day SMA (€) | 0.55845 | ||
| 12-1 Month Momentum % | -45.83 | ||
| 52-Week Range (€) | 0.442 - 1.09 | ||
| Shares Outstanding (Mil) | 97.96 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
ReproCELL Incorp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
ReproCELL Incorp Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| 5:1 Stock Split | 2013-08-28 | 15.44 (+0.00%) |
Show
Entries
ReproCELL Incorp Frequently Asked Questions
What is ReproCELL Incorp(FRA:6RC)'s stock price today?
The current price of FRA:6RC is €0.73. The 52 week high of FRA:6RC is €1.09 and 52 week low is €0.44.
When is next earnings date of ReproCELL Incorp(FRA:6RC)?
The next earnings date of ReproCELL Incorp(FRA:6RC) is .
Does ReproCELL Incorp(FRA:6RC) pay dividends? If so, how much?
ReproCELL Incorp(FRA:6RC) does not pay dividend.
Press Release
Articles on ReproCELL Incorp
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers